Question:
What is the status indicator change for Q5118?
Answer:
According to the April Outpatient Perspective Payment System updates in Transmittal 10013: “The status indicator for HCPCS code Q5118 (Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg) will be changed retroactively from status indicator =”E2” to status indicator = “K”, Effective January 13, 2020.”